ASCO: Durable Responses to Olaparib in Relapsed Ovarian Cancer Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present

#ovariancancers



Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Saturday, June 11, 2016

ASCO: Durable Responses to Olaparib in Relapsed Ovarian Cancer



medical news
 June 9, 2016

Median increased survival with BRCA mutation was 4.7 months

0 comments :

Post a Comment

Your comments?